medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-13-71-78medsovet-1989Research ArticleБеременность и родыPregnancy and childbirthТРОМБОФИЛИИ В АКУШЕРСКО-ГИНЕКОЛОГИЧЕСКОЙ ПРАКТИКЕ. ГЕПАРИНОПРОФИЛАКТИКАTHROMBOPHILIAS IN OBSTETRICIAN AND GYNECOLOGICAL PRACTICE, HEPARIN PREVENTIONМопотА. П.MomotA. P.

д.м.н., профессор, 

Барнаул

MD, Prof., 

Barnaul

НиколаеваМ. Г.NikolaevaM. G.

к.м.н.,

Барнаул

PhD in medicine,

Barnaul

Алтайский государственный медицинский университетРоссияAltay State Medical UniversityRussian Federation2017081020170137178Copyright © Мопот А.П., Николаева М.Г., 20172017Мопот А.П., Николаева М.Г.Momot A.P., Nikolaeva M.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1989

В обзоре освещаются вопросы эволюции учения о тромбофилии, представлен новый взгляд на факторы тромбогенного риска и состояние тромботической готовности, предшествующие и сопутствующие критической сосудистой ишемии. Представлены собственные результаты и результаты других авторов по применению низкомолекулярного гепарина 2-го поколения – бемипарина натрия для профилактики тромботических и гестационных осложнений в практике акушера-гинеколога.

The abstract highlights the evolution of the doctrine of thrombophilia, prsents a new perspective on factors of thrombogenic risk and the thrombotic state of readiness preceding and accompanying the critical vascular ischemia. Their own results and results of other authors are provided on the use of generation 2 low molecular weight heparin - bemiparin sodium for prevention of thrombotic and gestational complications in the practice of obstetrician-gynecologist.

система гемостазатромбофилияфакторы тромбогенного рискасостояние тромботической готовностиосложнения гестациинизкомолекулярные гепариныhemostasisthrombophiliathrombogenic risk factorsthrombotic state of readinesscomplications of pregnancylow molecular weight heparinsReferencesРадзинский В.Е. Акушерская агрессия. М.: Медиабюро Статус презенс. 2011.Радзинский В.Е. Акушерская агрессия. М.: Медиабюро Статус презенс. 2011.Ушкалова E.A., Ткачева O.H., Чухарева Н.А. Проблемы безопасности применения лекарственных средств во время беременности и кормления грудью. Акушерство и гинекология, 2011, 2: 4-7.Ушкалова E.A., Ткачева O.H., Чухарева Н.А. Проблемы безопасности применения лекарственных средств во время беременности и кормления грудью. Акушерство и гинекология, 2011, 2: 4-7.Momot A, Taranenko I, Tsyvkina L, Semenova N, Molchanova I. The Risk Factors of Thrombogenic, Thrombophilia, and the Principle for Heparin Prophylaxis in Personalized Medicine. In: Özcan Başaran, Murat Biteker editors. Anticoagulation Therapy. Croatia: InTech; 2016: 47-67.Momot A, Taranenko I, Tsyvkina L, Semenova N, Molchanova I. The Risk Factors of Thrombogenic, Thrombophilia, and the Principle for Heparin Prophylaxis in Personalized Medicine. In: Özcan Başaran, Murat Biteker editors. Anticoagulation Therapy. Croatia: InTech; 2016: 47-67.Руководство по гематологии. 3-е изд. Под ред. Воробьева А.И., редактор. Т. 3. М.: ООО «Медико-технологическое предприятие Ньюдиамед»., 2005.Руководство по гематологии. 3-е изд. Под ред. Воробьева А.И., редактор. Т. 3. М.: ООО «Медико-технологическое предприятие Ньюдиамед»., 2005.Thrombophilia. Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence). IntAngiol, 2013, 32(2): 188-200.Thrombophilia. Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence). IntAngiol, 2013, 32(2): 188-200.Heit JA. Thrombophilia: Clinical and Laboratory Assessment and Manajement. In: Kitchens CS, Kessler CM, Konkle BA. editors. Consultative Hemostasis and Thrombosis. 3rd ed. Philadelphia: Saunders Elsevier; 2013: 205-239.Heit JA. Thrombophilia: Clinical and Laboratory Assessment and Manajement. In: Kitchens CS, Kessler CM, Konkle BA. editors. Consultative Hemostasis and Thrombosis. 3rd ed. Philadelphia: Saunders Elsevier; 2013: 205-239.Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol, 2008, 143(3): 321–335.Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol, 2008, 143(3): 321–335.Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD. et al. Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol, 2006, 132(2): 171–196.Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD. et al. Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol, 2006, 132(2): 171–196.Rodger MA, Walker MC, Smith GN, Wells PS, Ramsay T, Langlois NJ. et al. Is thrombophilia associated with placenta-mediated pregnancy complications? A prospectivecohort study. J Thromb Haemost, 2014, 12(4): 469–478.Rodger MA, Walker MC, Smith GN, Wells PS, Ramsay T, Langlois NJ. et al. Is thrombophilia associated with placenta-mediated pregnancy complications? A prospectivecohort study. J Thromb Haemost, 2014, 12(4): 469–478.Майлян Э.А., Майлян Д.Э. Основы молекулярной генетики и генетические факторы риска заболеваний. Медицинский вестник Юга России, 2016, 1: 33-40. DOI:10.21886/2219-8075-2016-1-33-40.Майлян Э.А., Майлян Д.Э. Основы молекулярной генетики и генетические факторы риска заболеваний. Медицинский вестник Юга России, 2016, 1: 33-40. DOI:10.21886/2219-8075-2016-1-33-40.Момот А.П., Тараненко И.А., Цывкина Л.П. Эволюция представлений о тромбофилии и ее роли в проблемах репродукции человека. Акушерство и гинекология, 2013, 2: 4-9.Момот А.П., Тараненко И.А., Цывкина Л.П. Эволюция представлений о тромбофилии и ее роли в проблемах репродукции человека. Акушерство и гинекология, 2013, 2: 4-9.Момот А.П., Цывкина Л.П., Тараненко И.А., Мамаев А.Н., Сердюк Г.В., Шахматов И.И. и др. Современные методы распознавания состояния тромботической готовности. Барнаул: Изд-во Алтайского государственного университета. 2011.Момот А.П., Цывкина Л.П., Тараненко И.А., Мамаев А.Н., Сердюк Г.В., Шахматов И.И. и др. Современные методы распознавания состояния тромботической готовности. Барнаул: Изд-во Алтайского государственного университета. 2011.Hale SA, Schonberg A, Badger GJ, Bernstein IM. Relationship between prepregnancy and early pregnancy uterine blood flow and resistance index. Reprod Sci, 2009, 16(11): 1091-1096.Hale SA, Schonberg A, Badger GJ, Bernstein IM. Relationship between prepregnancy and early pregnancy uterine blood flow and resistance index. Reprod Sci, 2009, 16(11): 1091-1096.Walfish M, Neuman A, Wlody D. Maternal haemorrhage. Br J Anaesth, 2009, 103(1): i47–56.Walfish M, Neuman A, Wlody D. Maternal haemorrhage. Br J Anaesth, 2009, 103(1): i47–56.Бицадзе В.О., Макацария А.Д., Хизроева Д.Х., Макацария Н.А., Яшенина Е.В., Казакова Л.А. Тромбофилия как важнейшее звено патогенеза осложнений беременности. Практическая медицина, 2012, 5: 22-29.Бицадзе В.О., Макацария А.Д., Хизроева Д.Х., Макацария Н.А., Яшенина Е.В., Казакова Л.А. Тромбофилия как важнейшее звено патогенеза осложнений беременности. Практическая медицина, 2012, 5: 22-29.Momot AP, Semenova NA, Belozerov DE, Trukhina DA, Kudinova IY. The Dynamics of the hemostatic Parameters in Physiological Pregnancy and After Delivery. J Hematol Blood Transfus Disord, 2016, 3: 005.Momot AP, Semenova NA, Belozerov DE, Trukhina DA, Kudinova IY. The Dynamics of the hemostatic Parameters in Physiological Pregnancy and After Delivery. J Hematol Blood Transfus Disord, 2016, 3: 005.Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol, 2011, 117(3): 691–703.Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol, 2011, 117(3): 691–703.Sultan AA, West J, Tata LJ, Fleming KM, NelsonPiercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol, 2012, 156(3): 366–373.Sultan AA, West J, Tata LJ, Fleming KM, NelsonPiercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol, 2012, 156(3): 366–373.Reducingthe Risk of Venous Thromboembolism during Pregnancyand the Puerperium. RCOG Green-top Guideline No. 37a. 2015.Reducingthe Risk of Venous Thromboembolism during Pregnancyand the Puerperium. RCOG Green-top Guideline No. 37a. 2015.Martinelli I, Battaglioli T, DeStefano V, Tormene D, Valdrè L, Grandone E, et al.; the GIT (Gruppo Italiano Trombofilia). The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost, 2008, 6(3): 494–498.Martinelli I, Battaglioli T, DeStefano V, Tormene D, Valdrè L, Grandone E, et al.; the GIT (Gruppo Italiano Trombofilia). The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost, 2008, 6(3): 494–498.Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol, 2008, 143(3): 321–335.Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol, 2008, 143(3): 321–335.Urato AC, Norwitz ER. A guide towards prepregnancy management of defective implantation and placentation. Best Pract Res Clin Obstet Gynaecol, 2011, 25(3): 367-387.Urato AC, Norwitz ER. A guide towards prepregnancy management of defective implantation and placentation. Best Pract Res Clin Obstet Gynaecol, 2011, 25(3): 367-387.Brosens I, Pijnenborg R, Vercruysse L, Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J Obstet Gynecol, 2011, 204(3): 193-201. doi: 10.1016/j.ajog.2010.08.009.Brosens I, Pijnenborg R, Vercruysse L, Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J Obstet Gynecol, 2011, 204(3): 193-201. doi: 10.1016/j.ajog.2010.08.009.Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med, 2009, 22(8): 633-635.Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med, 2009, 22(8): 633-635.Bates SM, Greer IA, Pabinger I et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133(6): 844S-886S. DOI 10.1378/ chest.08-0761.Bates SM, Greer IA, Pabinger I et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133(6): 844S-886S. DOI 10.1378/ chest.08-0761.Wang X, Bai T, Liu S et al. Association between Thrombophilia Gene Polymorphisms and Preeclampsia: A Meta-Analysis. PLoS One, 2014, 9(6): e100789. doi:10.1371/journal. pone.0100789. eCollection 2014.Wang X, Bai T, Liu S et al. Association between Thrombophilia Gene Polymorphisms and Preeclampsia: A Meta-Analysis. PLoS One, 2014, 9(6): e100789. doi:10.1371/journal. pone.0100789. eCollection 2014.Профилактика венозных тромбоэмболических осложнений в акушерстве и гинекологии. Клинические рекомендации (протокол лечения). Письмо Министерства здравоохранения Российской Федерации от 27 мая 2014 г. № 15-4/10/2-3792.Профилактика венозных тромбоэмболических осложнений в акушерстве и гинекологии. Клинические рекомендации (протокол лечения). Письмо Министерства здравоохранения Российской Федерации от 27 мая 2014 г. № 15-4/10/2-3792.Шмаков Р.Г., Кирющенков П.А., Пырегов А.В., Виноградова М.А., Баев О.Р., Кан Н.Е. и др. Исследование системы гемостаза во время беременности и после родов. Краткий протокол. Акушерство и гинекология, 2015, 4: 1-2.Шмаков Р.Г., Кирющенков П.А., Пырегов А.В., Виноградова М.А., Баев О.Р., Кан Н.Е. и др. Исследование системы гемостаза во время беременности и после родов. Краткий протокол. Акушерство и гинекология, 2015, 4: 1-2.Момот А.П. Проблема тромбофилии в клинической практике. Российский журнал детской гематологии и онкологии, 2015, 1: 36-48.Момот А.П. Проблема тромбофилии в клинической практике. Российский журнал детской гематологии и онкологии, 2015, 1: 36-48.Момот А.П., Лыдина И.В., Борисова О.Г., Елыкомов В.А., Цывкина Л.П. Экстракорпоральное оплодотворение и управление гемостазом. Проблемы репродукции, 2012, 18(6): 47-55.Момот А.П., Лыдина И.В., Борисова О.Г., Елыкомов В.А., Цывкина Л.П. Экстракорпоральное оплодотворение и управление гемостазом. Проблемы репродукции, 2012, 18(6): 47-55.Martinez-Zamora MA, Creus M, Tassies D, Reverter JC, Civico S, Francisco Carmona F. et al. Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and em bryo transfer. Hum Reprod, 2011, 26(3): 510-516.Martinez-Zamora MA, Creus M, Tassies D, Reverter JC, Civico S, Francisco Carmona F. et al. Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and em bryo transfer. Hum Reprod, 2011, 26(3): 510-516.Westerlund E, Henriksson P, Wallén NH, Hovatta O, Rodriguez-Wallberg K, Antovic A. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thromb Res, 2012, 130(4): 649-653.Westerlund E, Henriksson P, Wallén NH, Hovatta O, Rodriguez-Wallberg K, Antovic A. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thromb Res, 2012, 130(4): 649-653.Focus on Reproduction. News letter of the European Society of Human Reproduction and Embryology. 2011 Jan. http://www.eshre.eu.Focus on Reproduction. News letter of the European Society of Human Reproduction and Embryology. 2011 Jan. http://www.eshre.eu.Di Nisio M, Rutjes AW, Ferrante N, Tiboni GM, Cuccurullo F, Porreca E. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood, 2011, 118(10): 2670-2678.Di Nisio M, Rutjes AW, Ferrante N, Tiboni GM, Cuccurullo F, Porreca E. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood, 2011, 118(10): 2670-2678.Nyboe Andersen A, Goossens V, Bhattacharya S. The European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod, 2009, 24(6): 1267-1287.Nyboe Andersen A, Goossens V, Bhattacharya S. The European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod, 2009, 24(6): 1267-1287.Момот А.П., Лыдина И.В., Зоренко В.Ю., Борисова О.Г., Цывкина Л.П., Тараненко И.А. Факторы риска неудач экстракорпорального оплодотворения при нарушениях гемостаза и их коррекция. Гематология и трансфузиология, 2013, 2: 18-22.Момот А.П., Лыдина И.В., Зоренко В.Ю., Борисова О.Г., Цывкина Л.П., Тараненко И.А. Факторы риска неудач экстракорпорального оплодотворения при нарушениях гемостаза и их коррекция. Гематология и трансфузиология, 2013, 2: 18-22.Qublan H, Amarin Z, Dabbas M, Farraj AE, BeniMerei Z, Al-Akash H. et al. Low-molecularweight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb), 2008, 11(4): 246-253.Qublan H, Amarin Z, Dabbas M, Farraj AE, BeniMerei Z, Al-Akash H. et al. Low-molecularweight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb), 2008, 11(4): 246-253.Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost, 2009, 102(2): 360-370.Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost, 2009, 102(2): 360-370.Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M. et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess, 2006, 10(11): 1-110.Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M. et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess, 2006, 10(11): 1-110.American Society of Reproductive Medicine. Birmingham. Alabama. Antiphospholipid Antibodies Do Not Affect IVF Success. Fertil Steril, 2008, 90: S172-173.American Society of Reproductive Medicine. Birmingham. Alabama. Antiphospholipid Antibodies Do Not Affect IVF Success. Fertil Steril, 2008, 90: S172-173.Nelson SM. Is placental haemostasis relevant to recurrent implantation failure? Thromb Res, 2011, 127(3): S93-95.Nelson SM. Is placental haemostasis relevant to recurrent implantation failure? Thromb Res, 2011, 127(3): S93-95.Simur A, Ozdemir S, Acar H, Colakoğlu MC, Görkemli H, Balci O. et al. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol Obstet Invest, 2009, 67(2): 109-112.Simur A, Ozdemir S, Acar H, Colakoğlu MC, Görkemli H, Balci O. et al. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol Obstet Invest, 2009, 67(2): 109-112.Khizroeva D, Bitsadze V. Clinical value of thrombophilia diagnostics in women with repeated IVF failure. J Thromb Res, 2012, 130(1): S160.Khizroeva D, Bitsadze V. Clinical value of thrombophilia diagnostics in women with repeated IVF failure. J Thromb Res, 2012, 130(1): S160.Zaynulina M, Mirashvili M. The prevalence of congenital and acquired thrombophilia and hyperhomocysteinemia in women with repeated in vitro fertilization failure. J Thromb Res, 2012, 130(1): S160.Zaynulina M, Mirashvili M. The prevalence of congenital and acquired thrombophilia and hyperhomocysteinemia in women with repeated in vitro fertilization failure. J Thromb Res, 2012, 130(1): S160.Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. RCOG Green-top Guideline No. 37a. 2015.Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. RCOG Green-top Guideline No. 37a. 2015.Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E. et al. Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood, 2014, 123(6): 822-828.Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E. et al. Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood, 2014, 123(6): 822-828.Матюшкин А.И., Нуреев М.В., Ройтман Е.В., Андрианова М.Ю. Применение бемипарина в хирургии (обзор литературы). Consilium Medicum. Хирургия, 2013, 1: 5-8.Матюшкин А.И., Нуреев М.В., Ройтман Е.В., Андрианова М.Ю. Применение бемипарина в хирургии (обзор литературы). Consilium Medicum. Хирургия, 2013, 1: 5-8.Gonzalez JM. Use of bemiparin in pregnancy and puerperium. LAB. FCOS. ROVI S.A. MEDICAL DPT, 2012, 1270(2): 1–2.Gonzalez JM. Use of bemiparin in pregnancy and puerperium. LAB. FCOS. ROVI S.A. MEDICAL DPT, 2012, 1270(2): 1–2.Kakkar VV. A decade of contribution to therapeutic progress: bemiparin in the management of venous thromboembolism. Foreword. Drugs, 2010, 70(2): 1-2.Kakkar VV. A decade of contribution to therapeutic progress: bemiparin in the management of venous thromboembolism. Foreword. Drugs, 2010, 70(2): 1-2.Santamaria A, Vila J, Marco A et al. Clinical management using low-molecular-weight heparin (LMWH) in pregnant women with thrombophilia, thromboembolic disease (DVT) or thrombophilia-related maternoplacental syndrome: experience in one center. J Thromb Haemost, 2007, 5(2): P-W-587.Santamaria A, Vila J, Marco A et al. Clinical management using low-molecular-weight heparin (LMWH) in pregnant women with thrombophilia, thromboembolic disease (DVT) or thrombophilia-related maternoplacental syndrome: experience in one center. J Thromb Haemost, 2007, 5(2): P-W-587.Alalaf S. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome. Arch Gynecol Obstet, 2012, 285(3): 641–647.Alalaf S. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome. Arch Gynecol Obstet, 2012, 285(3): 641–647.Sharif KW, Ghunaim S. Management of 273 cases of recurrent implantation failure: results of a combined evidence-based protocol. Reprod Biomed Online, 2010, 21(3): 373–380.Sharif KW, Ghunaim S. Management of 273 cases of recurrent implantation failure: results of a combined evidence-based protocol. Reprod Biomed Online, 2010, 21(3): 373–380.Лыдина И.В. Опыт использования бемипарина натрия для повышения результативности экстракорпорального оплодотворения. Тромбоз, гемостаз и реология, 2012, 52(4): 41-44.Лыдина И.В. Опыт использования бемипарина натрия для повышения результативности экстракорпорального оплодотворения. Тромбоз, гемостаз и реология, 2012, 52(4): 41-44.Cruz M, Fernández-Alonso AM, Rodríguez I, Garrigosa L, Caño A, Carretero P et al. Postcesarean thromboprophylaxis with two different regimens of bemiparin. Obstet Gynecol Int, 2011, 2011: 548327.Cruz M, Fernández-Alonso AM, Rodríguez I, Garrigosa L, Caño A, Carretero P et al. Postcesarean thromboprophylaxis with two different regimens of bemiparin. Obstet Gynecol Int, 2011, 2011: 548327.Будыкина Т.С., Сидоркина М.И., Прокопенко Е.И., Никольская И.Г. Эффективность применения бемипарина у беременных с хронической болезнью почек разных стадий. Эффективная фармакотерапия, 2016, 31: 4-11.Будыкина Т.С., Сидоркина М.И., Прокопенко Е.И., Никольская И.Г. Эффективность применения бемипарина у беременных с хронической болезнью почек разных стадий. Эффективная фармакотерапия, 2016, 31: 4-11.Лахно И.В. Состояние плода под влиянием антикоагулянтной терапии у беременных с преэклампсией. Акушерство и гинекология, 2014, 5: 27-32.Лахно И.В. Состояние плода под влиянием антикоагулянтной терапии у беременных с преэклампсией. Акушерство и гинекология, 2014, 5: 27-32.Alalaf SK, Jawad RK, Muhammad PR, Ali MS, Al Tawil NG. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial. BMC Pregnancy Childbirth, 2015, 15: 72. doi: 10.1186/s12884-015-0515-2.Alalaf SK, Jawad RK, Muhammad PR, Ali MS, Al Tawil NG. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial. BMC Pregnancy Childbirth, 2015, 15: 72. doi: 10.1186/s12884-015-0515-2.

The authors declare that there are no conflicts of interest present.